The aim of this study was to establish for the first time the prevalence of multiple sclerosis in the Bailiwicks of Guernsey and Jersey, as representing the most southerly part of the British Isles. All patients with multiple sclerosis in the Channel Islands resident on prevalence day were identified by contacting all medical practices, Multiple Sclerosis, and Action Research for Multiple Sclerosis societies by letter and visits. The crude overall prevalence rates were 1131100 000 (95% confidence interval (95% CI) 90-3-135.7) and 86-7/100 000 (95% CI 63.3-110.0) for the Bailiwicks of Jersey and Guernsey respectively. When standardised to the age and sex structure of a previously reported Northern Ireland population the standardised prevalence ratios were 120-21100 000 (95% CI 96-0-144-3) for Jersey and 95 61100 000 (95% CI 69-9-121.3) for the Bailiwick of Guernsey. When compared with recent studies in the northern United Kingdom the prevalence rates for multiple sclerosis in the Channel Islands lend some support to the proposed latitudinal gradient in the British Isles although the standardised prevalence ratio in the Bailiwick ofJersey is similar to those found in recent studies of southern Britain. The standardised prevalence rates of probable and definite multiple sclerosis for the male populations were 37 31100 000 (95% CI 17-9-56.7) for the Bailiwick of Guernsey and 45 51100 000 (95% CI 26.3-64.7) for the Bailiwick ofJersey whereas the standardised prevalence rates for the female populations were 97 51100 000 (95% CI 73-9-143.5) and 139*5/100 000 (95% CI 112-6-181-2) respectively. Thus there is a striking and unexplained 43% higher prevalence of probable and definite multiple sclerosis in the female population of Jersey compared with that of the Bailiwick of Guernsey. This seems to be due to an unusually low prevalence of the disease among the female population of the Bailiwick of Guernsey compared with that of the United Kingdom mainland.
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(3 Neurol Neurosurg Psychiatry 1995;58: [22] [23] [24] [25] [26] Keywords: multiple sclerosis; prevalence survey Multiple sclerosis is a common cause of serious neurological disability in young adults; it affects some 60 000 people in the United Kingdom and perhaps two million people worldwide.' The disease shows an unusual geographical distribution in becoming commoner with increasing distance from the Equator in both the northern and southern hemispheres.2 There is evidence for a similar geographical gradient in the British Isles.2 Different studies have reported multiple sclerosis to be 1 9 to 3 1 times commoner in women than men and to have a peak age of onset of about 30 years, being rare in childhood and after the age of 50.2 The clinical features, sex ratio, and age specific incidence curves for multiple sclerosis are similar whatever the underlying frequency of disease, suggesting the same worldwide aetiology.2
Among the many epidemiological surveys of multiple sclerosis in the past 40 years, several intriguing reports have studied the prevalence of the disease in geographically defined island populations. The Orkney and Shetland islands have the highest prevalence of the disease ever recorded-namely, 309 and 184 per 100 000 respectively.' The prevalence on Sardinia4 and Sicily5 has been reported to be over 45 per 100 000, whereas on nearby Malta the prevalence is tenfold lower.6 Clustering of cases of multiple sclerosis has been recorded on Orkney7 and on the small island of Key West off the coast of Florida.8 An "epidemic" of multiple sclerosis in the Faroes after occupation by British troops has been proposed,9 and a similar rise in prevalence after troop incursions has been claimed on Orkney,'0 Iceland," and Sardinia. ' Results The provisional register of potential patients with multiple sclerosis in the Channel Islands contained 193 names; of these 45 were eventually excluded because they were not resident on prevalence day (n = 8), or because the diagnosis of multiple sclerosis could not be confirmed (n = 9), or the person was not traced (n = 15). Additionally, one patient was registered with more than one practice and six were registered under both married and maiden names. Of the 45 patients 21 came from Jersey and 24 from Guernsey. A diagnosis of multiple sclerosis was accepted if it was confirmed by information from the patient's medical practitioner or from the medical notes. Some excluded patients had other diagnoses-for example, hereditary spastic paraparesis (which can mimic multiple sclerosis) (n = 4), Parkinson's disease (n = 1), or benign intracranial hypertension (n = 1). Others had suspicious symptoms but no signs (n = 9 Ninety four per cent of the patients of the Bailiwick of Guernsey and 88% of the patients on Jersey came under the "probable and possible" Allison and Millar classification20; 85% of the patients of the Bailiwick of Guernsey population and 88% of the Jersey population were fully classifiable under the system of Poser et al. '9 Of those who could not be readily classified under the Poser system 10 could not be categorised even with full clinical details (mainly those with progressive spinal cord disease) and with the remainder (n = 9) we were unable to attain sufficient clinical details to make classification possible. The four patients from Alderney in the Bailiwick of Guernsey (one male and three female) were all in the clinically definite category. Of the total identified cases of multiple sclerosis, 19 (13%) had a positive family history but in only 5% of cases was a first degree relative also affected. Only one affected sib pair was found on Guernsey, and one patient with a normal twin was resident on Jersey, as was one male patient with a sister not resident in the Channel Islands but being investigated for the disease elsewhere. Table 2 shows the overall crude preva- Age specific prevalence ofprobable and definite cases of multiple sclerosis (MS). 0-003; Guernsey, p = 0-5) than in the Northern Ireland population, which presumably reflects improved longevity of patients in the 30 years since that study was performed. 24 The familial incidence of multiple sclerosis in the Channel Islands also seems to be lower than in some surveys2 and only seven (5%) patients have a first degree relative also affected.
The striking finding in the present study is the unexpectedly high prevalence of female patients with probable or definite multiple sclerosis on Jersey compared with the Bailiwick of Guernsey (139-5/100 000 v 97-5/100 000), which largely accounts for the difference in overall prevalence between the two populations (table 3). The female:male ratios of the general population of the two Bailiwicks are almost identical (1:1 *07 and 1:1 05). Because the methods of ascertainment were the same on both sets of islands and because only probable or definite cases were included, this difference seems to be real. The observed prevalence per 100 000 females on Jersey is in line with that seen in recent surveys of southern Britain.' 148 Thus the female prevalence rate in the Bailiwick of Guernsey should be regarded as unusually low compared with mainland Britain. There is a dearth of prevalence data for nearby France, although a recent paper has quoted a figure of 40/100 000. 27 We are unaware of any established difference in the genetic make up of the populations of the two Bailiwicks and it is difficult to see why such factors should only apply to the female and not the male population.
